Mycophenolate Mofetil (CellCept)
Tacrolimus and Mycophenolate Mofetil as Maintenance Immunosuppressants
... the mycophenolate mofetil search included in the terms Cellcept, and the CAS registry ...or mycophenolate mofetil used as primary maintenance agents following kidney transplantation; ...
61
Reduction of peritoneal adhesion bands by mycophenolate mofetil (CellCept) and prednisolone in rats
... Mycophenolate mofetil (CellCept), known anti- inflammatory and immunosuppressive agent, has little effect on B cell and T cell. Presumably, this drug decreases adhesion formation prevalence by ceasing ...
6
Mycophenolate Mofetil Following Rituximab in Children With Steroid-Resistant Nephrotic Syndrome
... CNI, mycophenolate mofetil (MMF), alkylating agents, or various combinations of these steroid-sparing agents with or without steroid, is challenging, and therapeutic options are limited if patients do not ...
10
Clinical Features and Outcomes of Mycophenolate Mofetil-induced Diarrhea: A Systematic Review
... Mycophenolate Mofetil (MMF) is an immunosuppressive drug frequently used for prevention of graft rejection in solid-organ and hematopoietic stem cell ...
9
Mycophenolate mofetil plus prednisolone combination therapy for necrotising leukoencephalitis in a dog: long-term clinical observation, serial imaging analysis and histopathological findings
... under mycophenolate mofetil plus prednisolone therapy and was ultimately diagnosed with necrotising ...after mycophenolate mofetil plus prednisolone ...
6
DEVELOPMENT OF ASSAY METHOD FOR MYCOPHENOLATE MOFETIL IN PHARMACEUTICAL DOSAGE FORM
... A simple, rapid and reproducible high performance reverse phase liquid chromatographic method has been developed for quantitative estimation of Mycophenolate mofetil in tablets form using a, Phenomenex 250 ...
9
Mycophenolate mofetil: safety and efficacy in the prophylaxis of acute kidney transplantation rejection
... Abstract: Mycophenolate mofetil (MMF), a prodrug of mycophenolic acid (MPA), is an inhibitor of inosine monophosphate dehydrogenase ...Enteric-coated mycophenolate sodium (EC-MPS) can be used as an ...
12
Mycophenolate mofetil
... sodium mycophenolate has been reported by Rihs et ...or mycophenolate mofetil, which is the mofetil ester of myophenolic acid, the active immunosuppresant (Moder, ...2003). ...
9
Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review
... MMF: Mycophenolate mofetil; RCT: Randomized controlled trials; ESRD: End-stage renal disease; BP: Blood pressure; ACEI: Angiotensin converting enzyme inhibitor; ARB: Angiotensin receptor blocker; CBM: ...
10
A case of developing progressive multifocal leukoencephalopathy while using rituximab and mycophenolate mofetil in refractory systemic lupus erythematosus
... Abstract: Progressive multifocal leukoencephalopathy (PML) is a central nervous system infection caused by John Cunningham (JC) virus reactivation in an immunocompromised patient. PML has various neurologic symptoms and ...
5
Mycophenolate mofetil reduces STAT3 phosphorylation in systemic lupus erythematosus patients
... (1). Mycophenolate mofetil (MMF) is an immunosuppressive agent that was first shown to be effective in preventing organ rejection in renal transplant patients, but more recently was found to be efficacious ...
12
A placebo-controlled pilot study of intensification of antiretroviral therapy with mycophenolate mofetil
... of Mycophenolate Mofetil on Immune Response and Plasma and Lymphatic Tissue Viral Load During and After Interruption of Highly Active Antiretroviral Therapy for Patients with Chronic HIV Infec- tion: A ...
5
Mycophenolate mofetil in patients with refractory systemic autoimmune myopathies: case series
... MMF: Mycophenolate mofetil; MMT: Manual Muscle Testing; MP: Methylprednisolone pulse therapy; Mu: Muscular; P: Pulmonary; PM: Polymyositis; Pred: Prednisone; RTX: Rituximab; SAM: Systemic autoimmune ...
5
Brief Communications Mycophenolate mofetil: A safe and promising immunosuppressant in neuromuscular diseases
... Article abstract—The authors report the use mycophenolate mofetil (MM) in the treatment of neuromuscular diseases. Thirty-eight patients (32 with MG, three with inflammatory myopathy, and three with chronic ...
5
To Determine Whether Mycophenolic Acid Area under the Curve Correlates with Disease Activity In Pediatric Lupus Nephritis Patients Treated with Mycophenolate Mofetil
... Mycophenolate mofetil is a relatively new drug which has been used routinely in the prophylaxis against graft rejection and in its treatment in the post renal transplant ...patients. Mycophenolate ...
80
Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc ILD) as induction therapy: a single centre, retrospective analysis
... (P = 0.003) in the CYC group. The mean percentage in- crease in FVC at 6 months compared to baseline was 10.84 ± 13.81 % in the CYC group and 6.07 ± 11.92 % in the MMF group. Both improvements were statistically ...
6
Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter study
... Background: The purpose of this study was to assess changes in gastrointestinal symptom severity in patients with autoimmune disease who were switched from mycophenolate mofetil to en[r] ...
9
Simultaneous Spectrophotometric Determination of Mycophenolate Mofetil and Its Active Metabolite in Human Plasma Using Chemometrics Methods
... A spectrophotometric method for selective complexation reaction and simultaneous determination of mycophenolate mofetil (MPM), and mycophenolic acid (MPA) using three multivariate chemometric methods, i.e. ...
10
Mycophenolate Mofetil Is Active Against SARS-CoV-2 in Vero E6 Cells
... or mycophenolate mofetil monotherapy has not been reported in patients with SARS-CoV or MERS-CoV ...and mycophenolate mofetil has been described in a retrospective observational study in Saudi ...
7
Mycophenolate mofetil alters the antioxidant status in duodenum of rats: Implication for silymarin usage in mycophenolate mofetil-induced gastrointestinal disorders
... purchased from Merck (Darmstadt, Germany). N-butanol was obtained from Carl Roth, GmbH Co. (Karlsruhe, Germany). Sulfanilamide was purchased from ACROS (Acros Chemical, Princeton, NJ, USA). All other chemicals were ...
7